New requirements and perspectives in initial drug selection for hypertension

Norman M Kaplan

Research output: Contribution to journalArticlepeer-review


The initial choice of an antihypertensive drug therapy must be made carefully in order to improve upon the currently inadequate management of hypertension. At the same time, the choices should be based on the strongest objective evidence, which is primarily data from large-scale placebo-controlled randomized trials. The recommendations offered in the sixth report of the U.S. Joint National Committee and the 1999 World Health Organization - International Society of Hypertension Guidelines appear to meet the current criteria for correct choices of initial therapy.

Original languageEnglish (US)
Pages (from-to)L1-L4
JournalEuropean Heart Journal, Supplement
Issue numberL
StatePublished - Jan 1 1999


  • Drug therapy
  • Hypertension
  • Initial therapy for hypertension
  • Joint National Committee

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'New requirements and perspectives in initial drug selection for hypertension'. Together they form a unique fingerprint.

Cite this